Blog
Is the Worst Over for JPMorgan Chase?
When the coronavirus pandemic swooped down on the economy in March, it created a situation that very few could have imagined in January or February. The pandemic forced all banks to set aside huge
Is Ambarella an Underappreciated Artificial Intelligence Chip Stock?
Ambarella (NASDAQ: AMBA), which produces image processing SoCs (system on chips) and computer vision chips, isn't usually mentioned in conversations about artificial intelligence (AI) chips, which
Could Vertex Pharmaceuticals Be a Millionaire-Maker Stock?
It's no secret that investing in the stock market can make you rich. Then again, not all stocks fall into the category of millionaire-makers. In fact, many don't.
The good news is, you don't have
20% of Americans Have Changed Their Financial Plan Due to the Coronavirus
The coronavirus has necessitated major changes in the United States. For many people, some of those changes have to do with their money management. In fact, Northwestern Mutual reports as many as
Has Inovio Stock Peaked?
Even as the market plunged due to the economic fallout from the coronavirus pandemic, some companies managed to perform well. One of these was Inovio Pharmaceuticals (NASDAQ: INO), a biotech whose
Is CRISPR Therapeutics Stock a Good Buy Now, or Is It Too Late?
In mid-June, the gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) released new and highly positive data from two small clinical trials of its CTX001 gene-editing therapy for beta thalassemia
5 Potential Blockbuster IPOs to Add to Your Watch List
The market for companies going public has been heating up this year on the heels of the rapid-fire bear market and subsequent recovery. After losing 30% of its value between mid-February and late
Could Snowflake Be a Millionaire-Maker Stock?
Investors in general -- and technology investors in particular -- are always looking for their next multibagger opportunity. In the past five years or so, a number of cloud-based software companies
3 Top Stocks to Buy If the Market Woes Drag On
This year has certainly been one for the record books. The major market indexes began their record-setting coronavirus-induced swoon on Feb. 19, and the Dow Jones Industrial Average eventually
3 Tax Tips You Need to Invest During a Recession
In case you somehow missed the memo, our economy is stuck in a recession, and things could stay that way until there's a widely available vaccine or treatment to target COVID-19. What that really
1 Top Tech Stock That's Beating the Nasdaq Correction
All of a sudden, tech stocks are getting walloped.
The tech-heavy Nasdaq (NASDAQINDEX: ^IXIC) has sunk more than 10% in just three sessions, putting it in correction territory, while the sudden
6 Companies Racing to Mass-Produce a Coronavirus Vaccine in 2021
Under normal circumstances, it would be considered highly unusual for a biotech or pharmaceutical company to start building out manufacturing capacity for a drug that hasn't yet been approved by the
Better Marijuana Stock: OrganiGram vs. Curaleaf
Most cannabis companies have done well amid the coronavirus pandemic thanks to regular demand for marijuana, which is behaving more and more like a consumer good. U.S. pot companies in particular
3 Stock Market Tips for the Cautious Investor
If you're nervous about investing in the stock market, you're not alone. According to a recent Gallup Poll, only about 55% of Americans own stock, whether it's in the form of individual stocks
3 Healthcare Stocks I Can't Wait to Buy When the Stock Market Tanks Again
If you weren't paying attention during the last big stock market correction, don't worry. The next big dip is always right around the quarter.
If you plan to buy up shares of the best the
Roku Stock: Headed to $215?
Shares of Roku (NASDAQ: ROKU) got a boost on Tuesday, even as the overall market declined. The stock's gain came as Wells Fargo analyst Steven Cahall initiated coverage on the streaming platform
What to Like -- and Loathe -- About Aurora Cannabis' Latest Update
You probably expected that Aurora Cannabis (NYSE: ACB) would have announced its fiscal 2020 fourth-quarter results by now. After all, it's been nearly four months since the Canadian cannabis
Should Investors Worry About Moderna Slowing Enrollment in Its Coronavirus Vaccine Trial?
Earlier this year, Moderna (NASDAQ: MRNA) quickly emerged as a leader in the race to develop a coronavirus vaccine. The biotech's messenger RNA (mRNA) technology helped Moderna move faster than most
3 Stay-at-Home Tech Stocks to Buy Right Now
There isn't much any of us can do in large groups these days. Concert venues are closed, many movie theaters remain shuttered, and many large, outside events have been canceled thanks to COVID-19
Is bluebird bio Stock a Buy?
bluebird bio (NASDAQ: BLUE) is a biotech company that specializes in gene editing, a technology that allows scientists to modify the genetic material of living organisms. Gene editing has the
3 Signs You're Ready to Claim Social Security
Signing up for Social Security is not a decision to take lightly. Those benefits will most likely end up playing a crucial role in helping you finance your retirement, so it's important to claim
3 Undeniably Brilliant Robinhood Stocks to Buy Right Now Even if the Market Crashes
You'd be better off not touching many of the most popular stocks on the Robinhood trading platform with a 10-foot pole. Some of them sport nosebleed valuations. Others are just too risky.
On the
The 3 Most Exciting Pot Stocks You're Overlooking
You might not know it by looking at the poor performance of most cannabis stocks over the past 17 months, but marijuana is projected to be one of the fastest-growing industries this decade. With
Why Online Gambling Stocks Will Surge in 2021
When the coronavirus caused nationwide lockdowns in March, state governments absorbed a tough financial blow, watching countless tax streams evaporate. Lawmakers' hunger for new income sources has
Want a Dividend You Can Trust? Try JPMorgan Chase
Investors rely on dividend stocks for their capacity to produce reliable income and capital appreciation. While the latter is achieved through a long-term investing strategy, the former is much more


